Skip to main content
SpringerLink
Log in

Pharmacological Treatment of Mood Disturbances, Aggression, and Self-Injury in Persons with Pervasive Developmental Disorders

  • Published:
Journal of Autism and Developmental Disorders Aims and scope Submit manuscript

Abstract

Aggression, self-injury, and mood disturbances in persons with autistic disorders, while not uncommon, do not constitute core features of autism. Moreover, these problems can occur for a variety of reasons, which need to be assessed in order to plan appropriate and frequently combined (behavioral-pharmacological) treatments. Drugs acting primarily in the dopaminergic, serotonergic, adrenergic, opioidergic, and glutamatergic systems all have been explored in the treatment of aggression and self-injury. While no single drug or class of medication has yet emerged as consistently effective, a number of drugs appear promising. Advances in the assessment of aggressive behaviors, the identification of predictors of drug response, and additional controlled clinical drug trials specifically aimed at these target behaviors are essential in improving the approach to these problematic behaviors in the context of autistic disorder.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

REFERENCES

  • Abbott, P., Blake, A., & Vincze, L. (1965). Treatment of mentally retarded with thioridazine. Diseases of the Nervous System, 26, 583–585.

    PubMed  Google Scholar 

  • Aman, M. G., & Singh, N. N. (1982). Methylphenidate in severely retarded residents and the clinical significance of stereotypic behavior. Applied Research in Mental Retardation, 3, 345–358.

    PubMed  Google Scholar 

  • Aman, M. G., White, A. J., & Field, C. (1984). Chlorpromazine effects on stereotypic and conditioned behaviour of severely retarded patients-a pilot study. Journal of Mental Deficiency Research, 28, 253–260.

    PubMed  Google Scholar 

  • Barron, J., & Sandman, C. A. (1983). Relationship of sedative-hypnotic response to self-injurious behavior and stereotypy by mentally retarded clients. American Journal of Mental Deficiency, 88, 177–186.

    PubMed  Google Scholar 

  • Baumeister, A. A., Todd, M. E., & Sevin, J. A. (1993). Efficacy and specificity of pharmacological therapies for behavioral disorders in persons with mental retardation. Clinical Neuropharmacology, 16, 271–294. (Abstract)

    PubMed  Google Scholar 

  • Breese, G. R., Criswell, H. E., Duncan, G. E., & Mueller, R. A. (1990). A dopamine deficiency model of Lesch-Nyhan disease-the neonatal-6-OHDA-lesioned rat. Brain Research Bulletin, 25, 477–484.

    PubMed  Google Scholar 

  • Campbell, M., Anderson, L. T., Small, A. M., Adams, P., Gonzalez, N. M., & Ernst M. (1993). Naltrexone in autistic children: behavioral symptoms and attentional learning. Journal of the American Academy of Child and Adolescent Psychiatry, 32, 1283–1291.

    PubMed  Google Scholar 

  • Campbell, M., Fish, B., Korein, J., Shapiro, T., Collins, P., & Koh, C. (1972). Lithium and chlorpromazine: a controlled crossover study of hyperactive severely disturbed young children. Journal of Autism and Childhood Schizophrenia, 2, 234–263.

    PubMed  Google Scholar 

  • Cook, E. H., & Leventhal, B. L. (1996). The serotonin system in autism. Current Opinion in Pediatrics, 8, 348–354.

    PubMed  Google Scholar 

  • Davanzo, P. A., & King, B. H. (1996). Open trial lamotrigine in the treatment of self-injurious behavior in an adolescent with profound mental retardation. Journal of Child and Adolescent Psychopharmacology, 6, 273–279.

    PubMed  Google Scholar 

  • de Koning, P., Mak, M., de Vries, M. H., Allsopp, L. F., Stevens, R. B., Verbruggen, R., Van den Borre, R., van Peteghem, P., Kohen, D., Arumainayagam, M., et al. (1994). Eltoprazine in aggressive mentally handicapped patients: a double-blind, placebo-and baseline-controlled multi-centre study. The Eltoprazine Aggression Research Group. International Clinical Psychopharmacology, 9(3), 187–194.

    PubMed  Google Scholar 

  • Ernst, M., Magee, H. J., Gonzales, N. M., Locascio, J. J., Rosenberg, C. R., & Campbell, M. (1992). Pimozide in autistic children. Psychophamarcology Bulletin, 28, 187–191.

    Google Scholar 

  • Fankhauser, M. P., Karumanchi, V. C., German, M. L., Yates, A., & Karumanchi, S. D. (1992). A double-blind, placebo-controlled study of the efficacy of transdermal clonidine in autism. Journal of Clinical Psychiatry, 53(3), 77–82.

    PubMed  Google Scholar 

  • Farber, J. M. (1987). Psychopharmacology of self-injurious behavior in the mentally retarded. Journal of the American Academy of Child and Adolescent Psychiatry, 26, 296–302.

    PubMed  Google Scholar 

  • Gordon, C. T., State, R. C., Nelson, J. E., Hamburger, S. D., & Rapoport, J. L. (1993). A double-blind comparison of clomipramine, desipramine, and placebo in the treatment of autistic disorder. Archives of General Psychiatry, 50, 441–447.

    PubMed  Google Scholar 

  • Haller, J., Makara, G. B., & Kruk, M. R. (1998). Catecholaminergic involvement in the control of aggression: Hormones, the peripheral sympathetic, and central noradrenergic systems. Neuroscience and Biobehavioral Reviews, 22(1), 85–97.

    PubMed  Google Scholar 

  • Ireland, W. W. (1898). The mental affections of children, idiocy, imbecility and insanity. London: J & A Churchill.

    Google Scholar 

  • Jaselskis, C. A., Cook, E. H., Jr., Fletcher, K. E., & Leventhal, B. L. (1992). Clonidine treatment of hyperactive and impulsive children with autistic disorder. Journal of Clinical Psychopharmacology, 12, 322–327.

    PubMed  Google Scholar 

  • King, B. H., Cromwell, H. C., Ly, H. T., Behrstock, S. P., Schmanke, T., & Maidment, N. T. (1998). Dopaminergic and glutamatergic interactions in the expression of self-injurious behavior. Developmental Neuroscience, 20, 180–187.

    PubMed  Google Scholar 

  • Kurland, A. A., & Goldberg, J. B. (1970). Piperacetazine (Quide) in the management of behavioral disorders in mildly retarded institutionalized boys. Current Therapeutic Research, 12, 798–804.

    PubMed  Google Scholar 

  • Le Vann, L. J. (1969). Haloperidol in the treatment of behavioural disorders in children and adolescents. Canadian Psychiatric Association Journal, 14, 217–220.

    PubMed  Google Scholar 

  • Le Vann, L. J. (1971). Clinical comparison of haloperidol with chlorpromazine in mentally retarded children. American Journal of Mental Deficiency, 75, 719–723.

    PubMed  Google Scholar 

  • Lewis, M. H., Bodfish, J. W., Powell, S. B., & Golden, R. N. (1995). Clomipramine treatment for stereotype and related repetitive movement disorders associated with mental retardation. American Journal on Mental Retardation, 100, 299–312.

    PubMed  Google Scholar 

  • Lewis, M. H., Bodfish, J. W., Powell, S. B., Parker, D. E., & Golden, R. N. (1996). Clomipramine treatment for self-injurious behavior of individuals with mental retardation: a double-blind comparison with placebo. American Journal on Mental Retardation, 100, 654–665.

    PubMed  Google Scholar 

  • Lowry, M. A., & Sovner, R. (1992). Severe behaviour problems associated with rapid cycling bipolar disorder in two adults with profound mental retardation. Journal of Intellectual Disability Research, 36 (Pt 3), 269–281.

    PubMed  Google Scholar 

  • Malick, J. G. (1978). Inhibition of fighting in isolated mice following repeated administration of lithium chloride. Pharmacology, Biochemistry & Behavior, 8, 579–581.

    Google Scholar 

  • McDougle, C. J., Holmes, J. P., Bronson, M. R., Anderson, G. M., Volkmar, F. R., Price, L. H., & Cohen, D. J. (1997). Risperidone treatment of children and adolescents with pervasive developmental disorders: A prospective open-label study. Journal of the American Academy of Child and Adolescent Psychiatry, 36, 685–693.

    PubMed  Google Scholar 

  • Mikkelsen, E. J. (1986). Low-dose haloperidol for stereotypic self-injurious behavior in the mentally retarded. New England Journal of Medicine, 315, 398–399.

    Google Scholar 

  • Mueller, K., & Nyhan, W. L. (1982). Pharmacologic control of pemoline induced self-injurious behavior in rats. Pharmacology, Biochemistry & Behavior, 16, 957–963.

    Google Scholar 

  • Mueller, K., Saboda, S., Palmour, R., & Nyhan, W. L. (1982). Self-injurious behavior produced in rats by daily caffeine and continuous amphetamine. Pharmacology, Biochemistry & Behavior, 17, 613–617.

    Google Scholar 

  • Purdon, S. E., Lit, W., Labelle, A., & Jones, B. D. (1994). Risperidone in the treatment of pervasive developmental disorder. Canadian Journal of Psychiatry, 39, 400–405.

    Google Scholar 

  • Quintana, H., Birmaher, B., Stedge, D., Lennon, S., Freed, J., Bridge, J., & Greenhill, L. (1995). Use of methylphenidate in the treatment of children with autistic disorder. Journal of Autism and Developmental Disorders, 25, 283–294.

    PubMed  Google Scholar 

  • Ratey, J., Sovner, R., Parks, A., & Rogentine K. (1991). Buspirone treatment of aggression and anxiety in mentally retarded patients: a multiple-baseline, placebo lead-in study. Journal of Clinical Psychiatry, 52(4), 159–162.

    PubMed  Google Scholar 

  • Ratey, J. J., Mikkelsen, E., Sorgi, P., Zuckerman, H. S., Polakoff, S., Bemporad, J., Bick, P., & Kadish, W. (1987). Autism: the treatment of aggressive behaviors. Journal of Clinical Psychopharmacology, 7, 35–41.

    PubMed  Google Scholar 

  • Ritvo, E. R., Yuwiler, A., Geller, E., Kales, A., Rashkis, S., Schicor, A., Plotkin, S., Axelrod, R. & Howard, C. (1971). Effects of L-dopa in autism. Journal of Autism and Childhood Schizophrenia, 1, 190–205.

    PubMed  Google Scholar 

  • Sandman, C. A. (1988). Beta-endorphin disregulation in autistic and self-injurious behavior: a neurodevelopmental hypothesis. Synapse, 2, 193–199.

    PubMed  Google Scholar 

  • Serrano, A. C., & Forbis, O. L., Jr. (1973). Haloperidol for psychiatric disorders in children. Diseases of the Nervous System. 34, 226–231.

    PubMed  Google Scholar 

  • Siegel, A., & Schubert, K. (1995). Neurotransmitters regulating feline aggressive behavior. Reviews in the Neurosciences, 6, 47–61.

    PubMed  Google Scholar 

  • Sivam, S. P. (1995). GBR-12909-induced self-injurious behavior: role of dopamine. Brain Research, 690(2), 259–263.

    PubMed  Google Scholar 

  • Smith, D. A., & Perry, P. J. (1992). Nonneuroleptic treatment of disruptive behavior in organic mental syndromes. Annals of Pharmacotherapy, 26, 1400–1408.

    PubMed  Google Scholar 

  • Sovner, R., Fox, C. J., Lowry, M. J., & Lowry, M. A. (1983). Fluoxetine treatment of depression and associated self-injury in two adults with mental retardation. Journal of Intellectual Disability Research, 37(Pt3), 301–311.

    Google Scholar 

  • Uvebrant, P., & Bauziene, R. (1994). Intractable epilepsy in children. The efficacy of lamotrigine treatment, including nonseizure-related benefits. Neuropediatrics, 25, 284–289.

    Google Scholar 

  • van Hemert, J. C. (1975). Pipamperone (Dipiperon, R3345) in troublesome mental retardates: A double-blind placebo controlled cross-over study with long-term follow-up. Acta Psychiatrica Scandinavica, 52, 237–245.

    PubMed  Google Scholar 

  • Willemsen-Swinkels, S. H., Buitelaar, J. K., Nijhof, G. J., & van England, H. (1995). Failure of naltrexone hydrochloride to reduce self-injurious and autistic behavior in mentally retarded adults. Double-blind placebo-controlled studies. Archives of General Psychiatry, 52, 766–773.

    PubMed  Google Scholar 

  • Worrall, E. P., Moody, J. P., & Naylor, G. J. (1975). Lithium in non-manic depressives: Antiaggressive effect and red blood cell lithium values. British Journal of Psychiatry, 126, 464–468.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Dartmouth Medical School, One Medical Center Drive, Lebanon, New Hampshire, 03756

    Bryan H. King

Authors
  1. Bryan H. King
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

King, B.H. Pharmacological Treatment of Mood Disturbances, Aggression, and Self-Injury in Persons with Pervasive Developmental Disorders. J Autism Dev Disord 30, 439–445 (2000). https://doi.org/10.1023/A:1005555624566

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1005555624566

Search

Navigation